Paediatric therapeutics are undergoing a fundamental transformation. The focus is shifting from symptom management and supportive care toward molecules that intervene earlier, act more precisely, and modify disease trajectories at their biological roots. Recent advances span immune-modulating therapies that delay disease onset, mechanism-based card